- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/08 - Bridged systems
Patent holdings for IPC class C07D 471/08
Total number of patents in this class: 2024
10-year publication summary
|
113
|
130
|
134
|
142
|
131
|
146
|
160
|
131
|
127
|
39
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4812 |
67 |
| Merck Sharp & Dohme LLC | 3715 |
57 |
| Wockhardt Limited | 199 |
48 |
| Boehringer Ingelheim International GmbH | 4529 |
41 |
| Purdue Pharma L.P. | 494 |
39 |
| Meiji Seika Pharma Co., Ltd. | 256 |
34 |
| Gilead Sciences, Inc. | 2183 |
30 |
| Neurosearch A/S | 156 |
30 |
| Skyhawk Therapeutics, Inc. | 144 |
27 |
| Novartis AG | 10346 |
22 |
| Janssen Pharmaceutica N.V. | 3233 |
22 |
| Vertex Pharmaceuticals Incorporated | 1600 |
22 |
| Nippon Chemiphar Co., Ltd. | 224 |
22 |
| Achillion Pharmaceuticals, Inc. | 160 |
21 |
| Hoffmann-La Roche Inc. | 3686 |
19 |
| Pfizer Inc. | 3366 |
19 |
| Takeda Pharmaceutical Company Limited | 2718 |
19 |
| Rigel Pharmaceuticals, Inc. | 510 |
18 |
| Amgen Inc. | 4348 |
17 |
| Centre National de La Recherche Scientifique | 10865 |
16 |
| Other owners | 1434 |